Germany, January 12 /PRNewswire/ -- MIDAS Research
has published a research report on the nanotechnology
company Arrowhead Research Corp. (Nasdaq: ARWR / Berlin
Exchange: HDP) with a 12 month target of USD 6.00
and a speculative buy recommendation. A copy of the
report is available in both German and English at
Arrowhead Research is developing products and intellectual
property in a number of nanotech fields including
novel drug delivery systems, semiconductor materials
and tools for atomic force microscopy.
As judged by the breadth
and diversity of Arrowheads intellectual property
the company is likely to gain much broader attention
by investors concludes MIDAS Research technology analyst
Karsten Siebert, CEFA, in his report.
MIDAS Research is
an independent stock research company with a global
focus on emerging industries like nanotech and biotech.
Recent reports have successfully highlighted stocks
like MorphoSys (GER), pSivida (AUS), Callisto Pharma
(USA) or EpiTan (AUS).
For further information
Source: MIDAS Research